Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,405	9,252	5,347	5,390	6,295	9,629
Trading Asset Securities	0.47	0.47	0.47	0.47	0.47	0.47
Cash & Short-Term Investments	9,406	9,252	5,347	5,391	6,295	9,629
Cash Growth	-12.89%	73.02%	-0.81%	-14.37%	-34.62%	36.78%
Accounts Receivable	829.85	519.81	459.88	385.52	463.56	275.22
Other Receivables	5.55	7.77	10.56	10.35	11.79	6.58
Receivables	835.39	527.58	470.43	395.88	475.35	281.8
Inventory	1,401	1,440	1,181	1,466	1,574	1,185
Prepaid Expenses	-	0.64	7.29	10.57	-	-
Other Current Assets	624.59	511.02	381.4	307.18	131.44	298.68
Total Current Assets	12,267	11,731	7,387	7,571	8,475	11,395
Property, Plant & Equipment	10,333	10,255	9,849	9,376	6,670	2,969
Long-Term Investments	199.91	203.67	133.78	142.73	49.51	53.21
Other Intangible Assets	723.69	728.5	685.04	703.85	777.87	768.46
Long-Term Deferred Tax Assets	282.3	278.12	210.37	158.88	88.28	52.2
Long-Term Deferred Charges	6.08	3.21	6.42	4.98	7.17	9.58
Other Long-Term Assets	745.49	682.61	750.4	876.48	1,759	938.51
Total Assets	24,557	23,882	19,021	18,833	17,827	16,185
Accounts Payable	1,347	207.08	135.44	167.85	240.08	248.83
Accrued Expenses	9.53	30.77	30.32	21.54	32.47	42.34
Short-Term Debt	761.51	301.22	1,247	746.25	161.47	743.51
Current Portion of Long-Term Debt	28.13	12.81	37.17	784.37	5.38	-
Current Income Taxes Payable	40.7	31.32	32.94	55.54	30.7	45.4
Current Unearned Revenue	59.4	30.61	35.81	10.48	17.81	14.64
Other Current Liabilities	155.4	1,393	1,399	1,624	936.28	123.01
Total Current Liabilities	2,402	2,006	2,918	3,410	1,424	1,218
Long-Term Debt	303.44	188.96	613.26	245.33	960.5	-
Long-Term Unearned Revenue	366.84	371.98	389.29	405.18	404.39	293.03
Total Liabilities	3,072	2,567	3,920	4,060	2,789	1,511
Common Stock	721.29	721.29	583.38	583.38	583.28	416.68
Additional Paid-In Capital	14,250	14,246	8,520	8,526	8,540	8,688
Retained Earnings	2,984	2,819	2,546	2,167	1,905	1,539
Treasury Stock	-109.06	-109.06	-155.13	-126.19	-94.67	-
Comprehensive Income & Other	24.36	23.17	12.77	14.45	14.69	8.23
Total Common Equity	17,871	17,700	11,507	11,164	10,949	10,652
Minority Interest	3,614	3,615	3,594	3,609	4,089	4,022
Shareholders' Equity	21,485	21,315	15,101	14,773	15,038	14,674
Total Liabilities & Equity	24,557	23,882	19,021	18,833	17,827	16,185
Total Debt	1,093	503	1,897	1,776	1,127	743.51
Net Cash (Debt)	8,312	8,749	3,450	3,615	5,168	8,886
Net Cash Growth	-9.27%	153.60%	-4.56%	-30.05%	-41.84%	26.22%
Net Cash Per Share	11.62	12.79	5.93	6.21	8.87	15.24
Filing Date Shares Outstanding	720.51	720.09	718.95	581.32	582.15	583.35
Total Common Shares Outstanding	720.51	720.09	582.75	581.68	582.15	583.35
Working Capital	9,865	9,725	4,469	4,161	7,051	10,177
Book Value Per Share	24.80	24.58	19.75	19.19	18.81	18.26
Tangible Book Value	17,148	16,971	10,822	10,460	10,171	9,883
Tangible Book Value Per Share	23.80	23.57	18.57	17.98	17.47	16.94
Buildings	-	1,963	1,958	1,815	1,357	988.18
Machinery	-	3,360	3,330	3,216	2,979	1,807
Construction In Progress	-	6,601	5,949	5,443	3,164	758.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.